Virax Biolabs Group Ltd (NASDAQ:VRAX) currently has a daily average trading volume of 1.49M but it saw 4024296 shares traded in last market. With a market cap of 4.08M USD, the company’s current market price of $1.73 came rising about 33.08 while comparing to the previous closing price of $1.30. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.00 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $1.18 while lowest mark touched by it was $1.9.
Taking a look at 20-day trading activity of Virax Biolabs Group Ltd (VRAX) gives us an average price of $1.2057, while its current price level is -56.75% below from 52-week high level whereas it is 188.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.3131 while that of 200 days or SMA-200 reads an average of $1.2390. A closer look into the stock’s movement over the week reveals that its volatility is standing at 24.32% during that period while stretching the period over a month that decreases to 20.50%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 70.14 which implies that the stock is in overbought territory.
Over the week, VRAX’s stock price is moving 58.72% up while it is 35.16% when we observe its performance for the past one month. Year-to-date it is 18.49% up and over the past year, the stock is showing a downside performance of -50.57%.
Currently, Virax Biolabs Group Ltd’s total number of outstanding shares is 2.36M. Company’s return on investment (ROI) stands at -107.09% and return on equity (ROE) at -129.10%. Stock’s beta reads 1.45. Stock has a price to book (P/B) ratio of 0.49 while price to sale or P/S ratio amounts to 51.04. Its return on asset (ROA) is -112.36% on average.
